Immunotherapy before surgery helps shrink tumors in patients with desmoplastic melanoma

New results from a clinical trial co-led by UCLA investigators demonstrate how treating desmoplastic melanoma, a rare and aggressive skin cancer, with immunotherapy before surgery can dramatically shrink or even eliminate tumors, sparing patients from more aggressive surgeries and preserving their quality of life.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup